SCOPUS 정보 검색 플랫폼

Volumn 99, Issue 7, 2002, Pages 2304-2309

Factors affecting duration of survival after onset of blastic transformation of chronic myeloid leukemia

(9) Wadhwa, Jyoti a,b Szydlo, Richard M a,b Apperley, Jane F a,b Chase, Andrew a,b Bua, Marco a,b Marin, David a,b Olavarria, Eduardo a,b Kanfer, Edward a,b Goldman, John M a,b

a IMPERIAL COLLEGE LONDON (United Kingdom)

b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; IDARUBICIN; IMATINIB; INTERFERON; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; TIOGUANINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOTRANSPLANTATION; BLAST TRANSFORMATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036530228 PISSN: 00064971 EISSN: None Source Type: Journal
DOI: 10.1182/blood.V99.7.2304 Document Type: Article

Times cited : (75)

References (30)

1
- 0033572876
- Chronic myelogenous leukemia in nonlymphoid blastic phase: Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients
- (1999) Cancer , vol.86 , pp. 2632-2641
- Sacchi, S.¹ Kantarjian, H.M.² O'Brien, S.³

2
- 16944363756
- Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
- (1997) Leukemia , vol.11 , pp. 1617-1620
- Kantarjian, H.M.¹ O'Brien, S.M.² Keating, M.³

3
- 0019503539
- Intensive chemotherapy with daunorubicin, 5-azacytidine, 6-thioguanine, and cytarabine (DATA) for the blastic transformation of chronic granulocytic leukemia
- (1981) Cancer Treat Rep , vol.65 , pp. 389-392
- Winton, E.F.¹ Miller, D.² Vogler, W.R.³

4
- 0021967414
- Treatment of blast crisis of chronic myelogenous leukemia with vincristine, prednisone, and cytarabine
- (1985) Cancer Treat Rep , vol.69 , pp. 923-924
- Cervantes, F.¹ Rozman, C.² Blade, J.³ Montserrat, E.⁴ Granena, A.⁵

5
- 0023698656
- Treatment of the blastic phase of chronic myelogenous leukemia with high-dose cytosine arabinoside
- (1988) Am J Clin Oncol , vol.11 , pp. 623-626
- Ernst, T.J.¹ Rosenthal, D.S.² Griffin, J.D.³ Canellos, G.P.⁴

6
- 0024386642
- Daunomycin, cytosin-arabinoside and VP-16 (DAV) for myeloid blast crisis of CML
- (1989) Blut , vol.58 , pp. 299-301
- Anger, B.¹ Heimpel, H.²

7
- 0026530876
- Non-aggressive therapy for chronic myeloid leukaemia in blastic transformation
- (1992) Cancer Chemother Pharmacol , vol.29 , pp. 323-325
- Liang, R.¹ Chan, T.K.² Chiu, E.³ Todd, D.⁴

8
- 0018923095
- Combination chemotherapy for terminal-phase chronic granulocytic leukemia: Cancer and Leukemia Group B studies
- (1980) Blood , vol.55 , pp. 29-36
- Coleman, M.¹ Silver, R.T.² Pajak, T.F.³

9
- 0029377420
- Options for therapy in chronic myeloid leukaemia
- (1995) Br J Haematol , vol.91 , pp. 2-7
- Spencer, A.¹ O'Brien, S.G.² Goldman, J.M.³

10
- 0028177902
- Long-term survivors in chronic granulocytic leukaemia: A study by the International CGL Prognosis Study Group
- Italian Cooperative CML Study Group
- (1994) Br J Haematol , vol.87 , pp. 293-300
- Cervantes, F.¹ Robertson, J.E.² Rozman, C.³

11
- 0002714025
- Chronic myelogenous leukemia
- Hoffman R, Benz EJ, Shattil SJ, eds. New York, NY: Churchill Livingstone
- (2000) Hematology: Basic Principles and Practice , pp. 1155-1171
- Enright, H.¹ McGlave, P.²

12
- 17944362060
- Stem cell transplantation for chronic myeloid leukemia: The role of infused marrow cell dose
- (2001) Hematol J , vol.2 , pp. 265-271
- Pocock, C.F.¹ Szydlo, R.M.² Craddock, C.³

13
- 0025027347
- A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia
- (1990) Br J Haematol , vol.76 , pp. 27-32
- Cervantes, F.¹ Rozman, M.² Rosell, J.³ Urbano-Ispizua, A.⁴ Montserrat, E.⁵ Rozman, C.⁶

14
- 0027397997
- Chronic myelogenous leukemia in the lymphoid blastic phase: Characteristics, treatment response, and prognosis
- (1993) Am J Med , vol.94 , pp. 69-74
- Derderian, P.M.¹ Kantarjian, H.M.² Talpaz, M.³

15
- 0028333803
- Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan
- (1994) Am J Hematol , vol.45 , pp. 283-287
- Matulonis, U.A.¹ Griffin, J.D.² Canellos, G.P.³

16
- 0021331114
- Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis
- (1984) Am J Hematol , vol.16 , pp. 105-112
- Thomas, M.R.¹ Robinson, W.A.² Dantas, M.³ Koeppler, H.⁴ Drebing, C.⁵ Glode, L.M.⁶

17
- 9544230795
- Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemia
- (1996) Br J Haematol , vol.94 , pp. 694-698
- Rule, S.A.¹ Savage, D.G.² O'Brien, S.G.³

18
- 0029939567
- Allogeneic bone marrow transplantation for chronic myeloid leukemia
- Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation (EBMT)
- (1996) Bone Marrow Transplant , vol.17 , Issue.SUPPL. 3
- Gratwohl, A.¹ Hermans, J.²

19
- 0030003140
- Marrow transplantation for CML: The Seattle experience
- (1996) Bone Marrow Transplant , vol.17 , Issue.SUPPL. 3
- Clift, R.A.¹ Storb, R.²

20
- 0033855934
- Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia
- (2000) Br J Haematol , vol.109 , pp. 722-728
- Visani, G.¹ Rosti, G.² Bandini, G.³

21
- 0035810147
- Efficacy and safety of a specific inhibitor of BCR-ABL tyrosine kinase in chronic myeloid leukemia
- (2001) N Engl J Med , vol.344 , pp. 1031-1037
- Druker, B.J.¹ Talpaz, M.² Resta, D.J.³

22
- 0035810142
- Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
- (2001) N Engl J Med , vol.344 , pp. 1038-1042
- Druker, B.J.¹ Sawyers, C.L.² Kantarjian, H.³

23
- 0023195866
- The karyotype of blastic crisis
- (1987) Cancer Genet Cytogenet , vol.26 , pp. 39-50
- Alimena, G.¹ De Cuia, M.R.² Diverio, D.³ Gastaldi, R.⁴ Nanni, M.⁵

24
- 0020084611
- Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: A study of 69 cases
- (1982) Scand J Haematol , vol.28 , pp. 103-117
- Alimena, G.¹ Dallapiccola, B.² Gastaldi, R.³

25
- 0030061157
- Significance of cytogenetic clonal evolution in chronic myelogenous leukemia
- (1996) J Clin Oncol , vol.14 , pp. 196-203
- Majlis, A.¹ Smith, T.L.² Talpaz, M.³ O'Brien, S.⁴ Rios, M.B.⁵ Kantarjian, H.M.⁶

26
- 0023634256
- Chronic myelogenous leukemia in blast crisis: Analysis of 242 patients
- (1987) Am J Med , vol.83 , pp. 445-454
- Kantarjian, H.¹ Keating, M.J.² Talpaz, M.³

27
- 0022401296
- Chronic granulocytic leukemia: Correlation of blastic transformation type with karyotypic evolution
- (1985) Am J Hematol , vol.20 , pp. 313-323
- O'Malley, F.M.¹ Garson, O.M.²

28
- 0026590344
- Therapeutic and prognostic value of modal number of chromosomes at the blastic phase of Philadelphia-chromosome-positive chronic myeloid leukemia: Comparison based on the same criteria between Nagasaki University and Roswell Park Memorial Institute
- (1992) Acta Haematol , vol.87 , pp. 49-53
- Sadamori, N.¹ Yao, E.² Mine, M.³

29
- 0029802820
- Chronic myelogenous leukemia blast crisis: Retrospective analysis of prognostic factors in 90 patients
- (1996) Ann Hematol , vol.73 , pp. 225-230
- Griesshammer, M.¹ Heize, B.² Hellmann, A.³

30
- 0035080416
- Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells
- (2001) Leukemia , vol.15 , pp. 342-347
- Topaly, J.¹ Zeller, W.J.² Fruehauf, S.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.